A Phase 1 trial shows a personalized DNA vaccine (GNOS-PV01) is safe and doubles survival rates for aggressive glioblastoma.

An old adage claims a marine’s career came down to the “two or three minutes of a promotions brief.” Turns out that was a ...

Ta’ziz, a chemical affiliate of the Abu Dhabi National Oil Co. (ADNOC), has signed an agreement with Alpha Dhabi Holding to ...

Avingtrans PLC - Cambridgeshire, England-based engineering firm - Subsidiary Adaptix Ltd gains CE certification for its orthopaedic 3D imaging system, Adaptix Ortho350. Notes that Adaptix is focused ...

Panko-breaded chicken nuggets, shaped as 6’s and 7’s, went on sale on May 1 as part of a limited-edition release in the ...

Q1 2026 Earnings Call May 13, 2026 8:00 AM EDTCompany ParticipantsHannes Wittig - Head of Investor RelationsTimotheus Höttges ...

With the 2025-26 season long since in the books, let’s take a few moments to look back at the performance of each member of ...

Good morning, everyone, and thank you for joining us today. Welcome to our half year results. We've delivered another very strong half with operating profit up by 12%. This performance reflects a ...

The Orange County Fourth Grade MathBee Invitational encourages students to consider careers in STEM-related fields.

A WashU Medicine-led clinical trial conducted at Siteman Cancer Center has found that a personalized vaccine to treat ...

Allied Market Research has released a report titled, 'Life Science IT Market Size, Share by Solution (Drug Discovery ...